Global Transmucosal Drug Delivery Devices Market – Industry Trends and Forecast to 2029

Market Analysis and Size

The global transmucosal drug delivery devices market is estimated to increase rapidly over the forecast period, attributed to the increasing emphasis on personalized treatment. According to the recent research, the prevalence rate of hypertension is rising significantly in India. Therefore, the high incidence of cardiovascular diseases, including hypertension, will enhance the demand for the market for transmucosal drug delivery devices. The transmucosal drug delivery device is designed to deliver drugs to a specific mucous membrane area.

Data Bridge Market Research analyses that the transmucosal drug delivery devices market is expected to grow at a CAGR of 6.20% during the forecast period and is likely to reach USD 72.06 billion by 2029.

Market Definition

Transdermal drug delivery devices, which transport medications through the skin for therapeutic purposes, are an alternative to oral intravascular, subcutaneous, and transmucosal routes. The transmucosal drug delivery system has several benefits over conventional drug administration routes, making it a highly profitable market for enterprises participating in its value chain. One of the most significant benefits of transmucosal medication administration is that it permits pharmaceuticals to bypass the body's natural defence mechanisms. The transmucosal drug delivery devices market is estimated to grow in the following years due to a large target audience that may require regular drug delivery devices for diagnosis and treatment.

Transmucosal Drug Delivery Devices Market Dynamics

Drivers

• Prevalence of chronic disorders

The increase in prevalence rate of chronic diseases will act as major driver influencing the market's growth rate. Along with this, the growing incidence rate of gastrointestinal diseases will propel the growth rate of transmucosal drug delivery devices market.   

• Use of therapeutic pharmaceuticals

The rise in consumption of drugs and therapeutic pharmaceuticals will further accelerate the demand for transmucosal drug delivery devices market.

Additionally, the rising adoption of self-injectable devices will majorly influence the transmucosal drug delivery devices market's growth rate. The germination of various health problems such as autoimmune diseases and respiratory problems will increase the demand for transmucosal drug delivery devices and further propel the market's growth rate. Another significant factor resulting in the expansion of market is the advancement of technology. Furthermore, surging healthcare spending capacity and advancement in healthcare infrastructure are the major drivers that will enhance the growth of market. The rise in the adoption rate of third-generation transdermal drug delivery systems such as iontophoresis will influence the market's growth rate of transmucosal drug delivery devices.

Opportunities

• Growth in R&D activities

The rise in the number of research and development activities and favourable government policies regarding healthcare infrastructure will provide beneficial opportunities for the transmucosal drug delivery devices market growth. Moreover, rise in government investments for the development of technology and launch of innovative products will further expand the transmucosal drug delivery devices market's growth rate in the future.

Restraints/Challenges

On the other hand, the devices' high cost will obstruct the market growth. Also, complications linked with these delivery systems such as irritation at the site of application and edema will pose a major challenge for transmucosal drug delivery devices market. However, frequent changes in guidelines and regulations for combination products and the lack of skilled professionals will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This transmucosal drug delivery devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the transmucosal drug delivery devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Transmucosal Drug Delivery Devices Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. Most pharmaceutical companies and governments are attempting to provide effective medical treatment to COVID-19 patients following the pandemic outbreak, and medication delivery devices are expected to play a key role in this regard. With the second wave of the COVID-19 pandemic, the rising rate of vaccination and rising number of COVID-19 patients has had a beneficial influence on the drug delivery device market.

Recent Development

• In January 2021, Novartis AG had acquired the Credence MedSystems to help with the development and scale-up of their drug delivery systems. Novartis AG will be able to use the Credence technology in its injectable medicines due to this endeavour.

Global Transmucosal Drug Delivery Devices Market Scope

The transmucosal drug delivery devices market is segmented on the basis of type, indication, drug type, end user and route of administration. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Passive Transdermal Drug Delivery
• Active Transdermal Drug Delivery

Based on type, the transmucosal drug delivery devices market is segmented into passive transdermal drug delivery, and active transdermal drug delivery.

Drug Type

• Buccal Tablets
• Oral Sprays
• Sublingual Films and Wafers
• Gels
• Medicated Confectionery
• Others

Based on drug type, the transmucosal drug delivery devices market is fragmented into buccal tablets, oral sprays, sublingual films and wafers, gels, medicated confectionery, others.

Indication

• Pain Management
• Addiction Treatment
• Hormonal Therapies
• Others

Based on indication, the transmucosal drug delivery devices market is bifurcated into pain management, addiction treatment, hormonal therapies, and others.

Route of Administration

• Buccal
• Nasal
• Vaginal
• Urethral

Based on route of administration, the transmucosal drug delivery devices market is fragmented into buccal, nasal, vaginal, and urethral.

End User

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Hospitals

Transmucosal drug delivery devices market has also been segmented based on the end user into hospitals, diagnostic centers, and others.

Transmucosal Drug Delivery Devices Market Regional Analysis/Insights

The transmucosal drug delivery devices market is analysed and market size insights and trends are provided by country, type, indication, drug type, end user and route of administration as referenced above.

The countries covered in the transmucosal drug delivery devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the transmucosal drug delivery devices market because of the prevalence of chronic disorders in this region. Asia-Pacific is expected to grow during the forecast period due to presence of well-established market players in this region. 

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The transmucosal drug delivery devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for transmucosal drug delivery devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the transmucosal drug delivery devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Transmucosal Drug Delivery Devices Market Share Analysis

The transmucosal drug delivery devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to transmucosal drug delivery devices market.

Some of the major players operating in the transmucosal drug delivery devices market are Teva Pharmaceutical Industries Ltd., Slan Medicinal Holdings LTD, MMB Healthcare, LLC., BioDelivery Sciences International, Inc. Mylan N.V., Novartis AG, Bristol-Myers Squibb Company, Bayer AG, Johnson & Johnson Private Limited, Antares Pharma, BD, 3M, Pfizer Inc., Boehringer Ingelheim International GmbH., Abbott, Endo International plc, Echo Pharmaceuticals B.V., B. Braun Melsungen AG, Baxter, GlaxoSmithKline plc, and Acrux Limited, among others.

SKU-52325